OPRM1 A118G SNP Effect on Striatal Dopamine Response to an IV Opiate
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Remifentanil (Primary)
- Indications Pain
- Focus Pharmacodynamics; Pharmacogenomic; Pharmacokinetics
- 01 Apr 2021 Biomarkers information updated
- 20 Nov 2013 Planned number of patients changed from 84 to 80 as reported by ClinicalTrials.gov.
- 08 Jul 2013 New trial record